The University of Chicago Header Logo

Connection

Peter Riedell to Vidarabine

Back to Details
This is a "connection" page, showing publications Peter Riedell has written about Vidarabine.
Peter Riedell
Connection Strength
0.058
Vidarabine
  1. Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial. Lancet. 2025 Jan 11; 405(10473):127-136.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.